25 years ago, the cause of Huntington's disease was discovered. Mutations on a single gene, the huntingtin gene, lead to an incorrect form of the correspondent protein. With the help of cryo-electron microscopy, the recently awarded Nobel Prize winning method, researchers have now decoded the three-dimensional, molecular structure of the healthy human huntingtin protein. An improved understanding of the structure and the function of the huntingtin protein could contribute to the development of new treatment methods in the future. The work of the researchers from the Max Planck Institute of Biochemistry in Martinsried and Ulm University has now been published in the journal Nature.
Huntington's disease often begins with emotional disturbances and is characterized by involuntary muscle movement and loss of mental ability. Until today, the neurological disease is one of the hereditary diseases still incurable and fatal. The protein HTT, also called huntingtin, plays the central role in Huntington's disease. For 25 years it has been known that mutations of the huntingtin gene, which is the blueprint for the same protein, cause Huntington's disease.
Although researchers have worked on it for many years, there are still many hurdles to overcome. Now Rubén Fernández-Busnadiego from the Department of Molecular Structural Biology at the MPI of Biochemistry and Stefan Kochanek, head of the Department of Gene Therapy at the University Hospital Ulm, have succeeded in decoding the molecular, three-dimensional structure of the huntingtin protein.
Stefan Kochanek and his team have been working on the production and purification of huntingtin for a long time. What has prevented a detailed analysis of the protein in recent decades? Fernández-Busnadiego, an expert in cryo-electron microscopy, mentions two main factors: "First of all, cryo-electron microscopy has only been optimized in recent years to look at protein structures with almost molecular resolution. The second reason is that the huntingtin protein is very flexible in its structure. Just now, we have found also a solution for this problem."
During the analysis, pictures of the protein are being taken from different perspectives under the microscope. The three-dimensional molecular structure can be computed from the large number of resulting images. For this, the protein must always be in the same conformation. Fernández-Busnadiego explains: "This would be similar to a person being photographed in the dark. If the person does not stand still for a while, the shot will be blurry."
To get a clear picture, the researchers in the Kochanek lab have been looking for other proteins that interact with huntingtin and stabilize it. That worked for the protein HAP40. "Huntingtin in connection with HAP40 is stabilized in a particular conformation. Thus, averaged over many pictures, we were able to derive the three-dimensional structure," said Kochanek. "If we remain in the analogy of the photo in the dark, then the protein acts like a chair for the photographed person. Sitting on it, the person moves much less and the image is much sharper with the same exposure time," adds Fernández-Busnadiego.
Why is the three-dimensional structure of huntingtin needed?
"Although we have known for some time that the mutation of the huntingtin gene has severe consequences, we still know relatively little about the function and tasks of the healthy protein," explains Kochanek. Proteins are the molecular machines of the cell. In order to fulfill their versatile tasks, they have a certain three-dimensional structure, similar to a specific component in a machine.
"Now that we know the exact structure of huntingtin, we can further study which areas of huntingtin are particularly important and how other proteins cooperate with huntingtin functionally. In this way structures could be deduced to be targeted therapeutically by certain drugs."
Right now, there is a lot going on in Huntington's disease research. Great hope is directed to a method, that mutes the huntingtin gene with so-called Antisense-Oligonukleotiden (ASO) for the treatment of Huntington's disease. These small molecules reduce the formation of huntingtin proteins in the cells, but the drug cannot differentiate between the normal and the pathologically altered huntingtin protein. Also for this reason, it is important to learn more about the function of the healthy huntingtin protein. Kochanek confidently looks into the future: "The decoded structure will bring us a big step ahead".
Comment from the clinician
Bernhard Landwehrmeyer is the Director of the Huntington Outpatient Clinic of the Neurology Department at the University Medical Center Ulm and heads the world's largest international cohort study on Huntington's disease (with more than 16,000 participants): "Identifying the structure of huntingtin is a huge step forward for the many families hoping for effective treatment for Huntington's disease. The illness partly arises due to new characteristics of the pathologically changed huntingtin gene products that are the result of the HD mutation, but also in part as a consequence of impaired normal functioning of huntingtin. Now - armed with the knowledge of the architecture of huntingtin - questions about the normal function of huntingtin can be clarified in a much quicker and more tightly focused way, and tailored drugs can be developed that promote normal function."
"The antisense oligonucleotide (ASO) treatment trials are presently only conducted at very few clinics; the Neurological University Clinic Ulm leads the drug testing for Germany. Some of the currently reviewed ASOs reduce both the formation of the normal and the mutant huntingtin protein, while other ASOs predominantly seek to lower the altered huntingtin. It is currently unclear whether a partial inhibition of the formation of normal huntingtin protein has disadvantages and is tolerated without undesirable side effects. This is yet another reason why it is important to learn more about the normal function of the huntingtin protein. To this end, the study published in the journal Nature will make an important contribution."
Q. Guo, B. Huang, J. Cheng, M. Seefelder, T. Engler, G. Pfeifer, P. Oeckl, M. Otto, F. Moser, M. Maurer, A. Pautsch, W. Baumeister, R Fernández-Busnadiego and S. Kochanek: The cryo-EM structure of huntingtin, Nature, February 2018
DOI: 10.1038 / nature25502
Dr. Rubén Fernández-Busnadiego
Molecular Structural Biology
Max-Planck-Institut für Biochemie
Am Klopferspitz 18
Dr. Christiane Menzfeld
Max-Planck-Institut für Biochemie
Am Klopferspitz 18
Tel. +49 89 8578-2824
Prof. Dr. Stefan Kochanek
Presse- und Öffentlichkeitsarbeit
Tel.: 0731-50 22121
Fax.: 0731-50 22048
http://www.biochem.mpg.de/en/news/pressroom - More press releases of the MPI of Biochemistry
http://www.biochem.mpg.de/en/rd/baumeister - Website of the research department „"Molecular Structural Biology"
https://twitter.com/MPI_Biochem - Twitter @MPI_Biochem
Dr. Christiane Menzfeld | Max-Planck-Institut für Biochemie
Molecular motors run in unison in a metal-organic framework
20.03.2019 | University of Groningen
Active substance from plant slows down aggressive eye cancer
20.03.2019 | Rheinische Friedrich-Wilhelms-Universität Bonn
Due to the special arrangement of its molecules, a new coating made of corn starch is able to repair small scratches by itself through heat: The cross-linking via ring-shaped molecules makes the material mobile, so that it compensates for the scratches and these disappear again.
Superficial micro-scratches on the car body or on other high-gloss surfaces are harmless, but annoying. Especially in the luxury segment such surfaces are...
The Potsdam Echelle Polarimetric and Spectroscopic Instrument (PEPSI) at the Large Binocular Telescope (LBT) in Arizona released its first image of the surface magnetic field of another star. In a paper in the European journal Astronomy & Astrophysics, the PEPSI team presents a Zeeman- Doppler-Image of the surface of the magnetically active star II Pegasi.
A special technique allows astronomers to resolve the surfaces of faraway stars. Those are otherwise only seen as point sources, even in the largest telescopes...
Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have proposed a way to create a completely new source of radiation. Ultra-intense light pulses consist of the motion of a single wave and can be described as a tsunami of light. The strong wave can be used to study interactions between matter and light in a unique way. Their research is now published in the scientific journal Physical Review Letters.
"This source of radiation lets us look at reality through a new angle - it is like twisting a mirror and discovering something completely different," says...
New research group at the University of Jena combines theory and experiment to demonstrate for the first time certain physical processes in a quantum vacuum
For most people, a vacuum is an empty space. Quantum physics, on the other hand, assumes that even in this lowest-energy state, particles and antiparticles...
Physicists in the EPic Lab at University of Sussex make crucial development in global race to develop a portable atomic clock
Scientists in the Emergent Photonics Lab (EPic Lab) at the University of Sussex have made a breakthrough to a crucial element of an atomic clock - devices...
11.03.2019 | Event News
01.03.2019 | Event News
28.02.2019 | Event News
20.03.2019 | Life Sciences
20.03.2019 | Life Sciences
20.03.2019 | Trade Fair News